Page 4 - Director Kristina Burow News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Director kristina burow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Director Kristina Burow Today - Breaking & Trending Today

Neumora Therapeutics (NASDAQ:NMRA) Earns Overweight Rating from Analysts at JPMorgan Chase & Co.

JPMorgan Chase & Co. started coverage on shares of Neumora Therapeutics (NASDAQ:NMRA – Get Free Report) in a research report issued to clients and investors on Tuesday, Marketbeat Ratings reports. The firm set an “overweight” rating and a $21.00 price target on the stock. JPMorgan Chase & Co.‘s target price points to a potential upside […] ....

United States , Stifel Nicolaus , William Blair , Kristina Burow , Jpmorgan Chase Co , Neumora Therapeutics Inc , Amgen Inc , Securities Exchange Commission , Royal Bank , Neumora Therapeutics Company Profile , Neumora Therapeutics , Get Free Report , Marketbeat Ratings , Therapeutics Trading Down , Director Kristina Burow , Exchange Commission , Neumora Therapeutics Daily , Nasdaq Nmra , Initiated Coverage , Jpmorgan Chase Co ,

Neumora Therapeutics (NASDAQ:NMRA) Trading Down 4.8%

Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report)’s stock price traded down 4.8% on Monday . The stock traded as low as $10.50 and last traded at $10.50. 124,789 shares changed hands during mid-day trading, a decline of 85% from the average session volume of 849,751 shares. The stock had previously closed at $11.03. Neumora […] ....

Kristina Burow , Neumora Therapeutics Inc , Neumora Therapeutics Company Profile , Amgen Inc , Neumora Therapeutics , Get Free Report , Director Kristina Burow , Neumora Therapeutics Daily , Nasdaq Nmra ,

Neumora Therapeutics (NASDAQ:NMRA) Shares Gap Up Following Insider Buying Activity

Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) shares gapped up prior to trading on Thursday following insider buying activity. The stock had previously closed at $10.13, but opened at $10.35. Neumora Therapeutics shares last traded at $10.08, with a volume of 57,388 shares changing hands. Specifically, major shareholder Amgen Inc bought 1,764,705 shares of […] ....

Kristina Burow , Amgen Inc , Neumora Therapeutics Company Profile , Securities Exchange Commission , Neumora Therapeutics Inc , Neumora Therapeutics , Get Free Report , Director Kristina Burow , Exchange Commission , Therapeutics Inc , Neumora Therapeutics Daily , Nasdaq Nmra ,